Work

A Phase 1 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Ara-C in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.2550.2550

Authors: Daniel J. DeAngelo, Amir T. Fathi, Lillian Werner, David Avigan, Katarina Luptakova, Martha Wadleigh, David P. Steensma, Gabriela Soriano Hobbs, Eyal C. Attar, Philip C. Amrein, Richard M. Stone, Karen K. Ballen

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553172767

FWCI:

Cites:

Cited by:

Related to: 10